报价延迟最少15分钟:2026/03/21 02:01 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.6 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.50/-0.57
|
|
企业价值
221.11M
|
| 资产负债 |
|
每股账面净值
0.56
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
59.35M
|
|
每股收益
0.82
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas. |
